NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK plc ("GSK" or "the Company") (NYSE:GSK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GSK American Depositary Receipts ("ADRs") between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Monolithic Power Systems, Inc. ("Monolithic Power Systems" or "the Company") (NASDAQ:MPWR) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Monolithic Power Systems securities between February 8, 2024 and November 8, 2024, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or "the Company") (NYSE:MRK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Merck securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ModivCare, Inc. ("ModivCare" or "the Company") (NASDAQ:MODV) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ModivCare securities between November 3, 2022 and September 15, 2024, both dates inclusive (the "Class Period").

NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Polestar Automotive Holding UK PLC ("Polestar" or "the Company") (NASDAQ:PSNY) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Polestar securities between November 14, 2022 and January 16, 2025, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TELUS International (Cda) Inc. ("TELUS" or "the Company") (NYSE:TIXT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TELUS securities between February 16, 2023 and August 1, 2024, both dates inclusive (the "Class Period").

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neumora Therapeutics, Inc. ("Neumora" or "the Company") (NASDAQ:NMRA) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Neumora securities pursuant to the registration statement and prospectus issued in connection with the Company's September 15, 2023 initial public offering ("IPO").

PHOENIX, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a pioneering biotechnology firm specializing in regenerative medicine solutions for immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced compelling mid-term follow-up data from its StemSpine® pilot study utilizing its AlloStem™ cells for the treatment of chronic lower back pain. The pilot study demonstrated a substantial reduction in opioid dependency and significant improvements in pain levels and functional mobility.

The hot field of artificial intelligence (AI) helped the stock market reach new highs in 2024. Quantum computing is another emerging technology with the potential to do the same.

The tech-heavy Nasdaq index has been a great place to look for stocks with immense upside. Tech stocks have gone mostly straight up since the start of 2023, and with how much money is flowing into the artificial intelligence (AI) investing space, I don't see this trend subsiding anytime soon.

Company also details benefits from Smart Energy Plan investments in a stronger grid that saved customers 8 million minutes in outages in 2024 ST. LOUIS , Feb. 14, 2025 /PRNewswire/ -- Ameren Missouri, a subsidiary of Ameren Corporation (NYSE: AEE), announced a significant change to its generation strategy, aiming to accelerate generation investments to support robust economic expansion, bolster reliability and create jobs across Missouri.

CORAL GABLES, Fla. , Feb. 14, 2025 /PRNewswire/ -- MasTec, Inc. (NYSE: MTZ) today announced that it will release results of operations for the quarter and year ended December 31, 2024, after the market closes on Thursday, February 27, 2025.

Fourth Quarter Net Sales and Adjusted EBITDA Met Guidance TreeHouse delivered fiscal year 2024 results: Net sales were $3,354.0 million Net income from continuing operations of $26.9 million Adjusted EBITDA1 was $337.4 million Fourth quarter results included: Net sales of $905.7 million Net income from continuing operations of $58.7 million Adjusted EBITDA1 of $118.3 million Issued initial fiscal year 2025 outlook for adjusted net sales in a range of $3.340 billion to $3.400 billion, adjusted EBITDA2 in a range of $345 million to $375 million, and free cash flow2 of at least $130 million. OAK BROOK, Ill.

Over the last couple of weeks, stocks in the technology sector have been selling off as investors entered a panic fueled by the Chinese artificial intelligence (AI) start-up DeepSeek. One AI company that has bucked the trend, however, is data analytics provider Palantir Technologies (PLTR 0.44%).

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, today reported financial results for the fourth quarter ended December 31, 2024. Fourth Quarter Consolidated Results Reported revenue increased 7.8% to $376.4 million in the fourth quarter of 2024 versus last year's fourth quarter results of $349.3 million. On a local currency basis(1), revenue increased 8.9%. Reported opera.

CRL's solid prospects in the DSA segment and strategic partnerships present a promising opportunity for investors.

GREENSBORO, N.C.--(BUSINESS WIRE)--Kontoor Brands, Inc. (NYSE: KTB), a global lifestyle apparel company, with a portfolio led by two of the world's most iconic consumer brands, Wrangler® and Lee®, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.52 per share of its common stock. The cash dividend will be payable on March 20, 2025, to shareholders of record at the close of business on March 10, 2025. About Kontoor Brands Kontoor Brands, Inc. (NYSE:.

Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.

FRSH, SFTBY, ATGE, FINW and PAHC have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2025.

If you are trying to set up a portfolio that will provide you with a lifetime of income, you'll want to take a close look at Enbridge (ENB 0.78%). Not only does this giant North American midstream company offer a compelling 6.1% dividend yield, but it is making moves today to ensure that it can continue to grow, even as the world shifts toward cleaner energy sources.